1. Home
  2. STEX vs LONA Comparison

STEX vs LONA Comparison

Compare STEX & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Streamex Corp.

STEX

Streamex Corp.

SELL

Current Price

$0.31

Market Cap

38.0M

Sector

N/A

ML Signal

SELL

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

HOLD

Current Price

$2.40

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEX
LONA
Founded
2009
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
32.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
STEX
LONA
Price
$0.31
$2.40
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $16.00
AVG Volume (30 Days)
★ 979.1K
57.8K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $18,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,314.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.26
$2.21
52 Week High
$4.76
$14.21

Technical Indicators

Market Signals
Indicator
STEX
LONA
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
STEX
LONA

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: